Summary

Intracoronary injection of skeletal muscle stem cells within days of myocardial infarction increases heart function after 1 year, according to findings of the Catheter-Based Delivery of Autologous Skeletal Myoblasts for Ischemic Cardiomyopathy: Feasibility, Safety and Improvement in Cardiac Performance [CAuSMIC] trial.